Brief: IN8bio Doses First Patient In Phase 2 Clinical Trial Of INB-400 In Newly Diagnosed Glioblastoma

IN8bio

30/04/2024 11:17

April 30 (Reuters) - IN8BIO, Inc.  INAB.O :
    * IN8BIO DOSES FIRST PATIENT IN PHASE 2 CLINICAL TRIAL OF
INB-400
IN NEWLY DIAGNOSED GLIOBLASTOMA
    * IN8BIO DOSES FIRST PATIENT IN PHASE 2 CLINICAL TRIAL OF
INB-400
IN NEWLY DIAGNOSED GLIOBLASTOMA

Source text for Eikon:  ID:nGNX594nqg 
Further company coverage:  INAB.O 

 (Reuters.Briefs@thomsonreuters.com)